Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00663507 · ClinicalTrials.gov registry record
Kidney Transplantation in Patients With Sickle Cell Disease
A clinical trial, sponsored by Emory University.
- Terminated
- Registry status
- 2
- Enrollment target
NCT00663507 is a clinical trial that was terminated before completion, run by Emory University. The registered enrollment target is 2 participants.
The verdict
NCT00663507 was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this research is to better characterize the components and mechanisms of the immune systems of persons with sickle cell disease who have had a kidney transplant and are immunosuppressed. If we can improve our scientific understanding of the fundamental mechanisms involved in patient outcomes, we can potentially maximize the benefits that we seek from transplantation in sickle cell patients with end stage renal disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2008-03 |
| Est. Completion | 2010-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00663507
The ClinicalTrials.gov registry entry for NCT00663507 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00663507 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00663507 about?
NCT00663507 is a clinical study titled "Kidney Transplantation in Patients With Sickle Cell Disease". The purpose of this research is to better characterize the components and mechanisms of the immune systems of persons with sickle cell disease who have had a kidney transplant and are immunosuppressed. If we can improve our scientific understanding of the fundamental mechanisms involved in patient o...
What is the current status of trial NCT00663507?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2008-03. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT00663507?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.